(Q37716948)

22 August 2017

ApoE variant p.V236E is associated with markedly reduced risk of Alzheimer's disease (English)

1 reference

22 August 2017

0 references

15

1 reference

22 August 2017

Nilüfer Ertekin-Taner

18

Nilüfer Ertekin-Taner

1 reference

22 August 2017

Joanna Siuda

11

0 references

Kevin Morgan

Kevin Morgan

19

0 references

Maria Barcikowska

Maria Barcikowska

10

0 references

Zbigniew K Wszolek

12

Zbigniew K Wszolek

1 reference

22 August 2017

17

Ronald C Petersen

1 reference

22 August 2017

13

Owen A Ross

1 reference

22 August 2017

Minerva M Carrasquillo

14

Minerva Carrasquillo

1 reference

22 August 2017

Neill R Graff-Radford

16

Neill Graff-Radford

1 reference

22 August 2017

6

Fanggeng Zou

1 reference

22 August 2017

7

Shane Pankratz

1 reference

22 August 2017

5

Gina Bisceglio

1 reference

22 August 2017

8

Sigrid B Sando

1 reference

22 August 2017

1

Christopher W Medway

1 reference

22 August 2017

2

Samer Abdul-Hay

1 reference

22 August 2017

Tynickwa Mims

3

1 reference

22 August 2017

Li Ma

4

1 reference

22 August 2017

Jan O Aasly

9

1 reference

22 August 2017

Guojun Bu

20

1 reference

22 August 2017

Steven G Younkin

21

1 reference

22 August 2017

10 March 2014

1 reference

Molecular Neurodegeneration

22 August 2017

1 reference

22 August 2017

9

1 reference

22 August 2017

11

1 reference

TREM2 Variants in Alzheimer's Disease

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995879

Variant of TREM2 Associated with the Risk of Alzheimer's Disease

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995879

Structural differences between apoE3 and apoE4 may be useful in developing therapeutic agents for Alzheimer's disease

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995879

Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995879

Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995879

APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995879

PLINK: a tool set for whole-genome association and population-based linkage analyses

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995879

Role of Genes and Environments for Explaining Alzheimer Disease

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995879

The International HapMap Project

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995879

Characterization of five new mutants in the carboxyl-terminal domain of human apolipoprotein E: no cosegregation with severe hyperlipidemia.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995879

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995879

Interleukin-1 gene -511 CT polymorphism and the risk of Alzheimer's disease in a Polish population.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995879

Apolipoprotein E Pittsburgh variant is not associated with the risk of late-onset Alzheimer's disease in a Spanish population.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995879

A novel mutation in the apolipoprotein E gene (APOE*4 Pittsburgh) is associated with the risk of late-onset Alzheimer's disease.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3995879

Screening of two mutations at exon 3 of the apolipoprotein E gene (sites 28 and 42) in a sample of patients with sporadic late-onset Alzheimer's disease

1 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24607147

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Lipoprotein profiles in a family with two mutants of apolipoprotein E: possible association with hypertriglyceridaemia but not with dysbetalipoproteinaemia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24607147

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The Impact of Mitochondrial and Nuclear DNA Variants on Late-Onset Alzheimer's Disease Risk

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24607147

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1750-1326-9-11

1 reference

Dimensions Publication ID

22 August 2017

0 references

1 reference

22 August 2017

PubMed publication ID

24607147

1 reference